Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Nutraceutical Clinical Laboratories International, Inc., Secures $2 Million in Funding
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- European Parliament Passes Second Reading On Fortified Foods Regulations
The European Parliament voted yesterday on EU Fortified Foods Regulations yesterday, with the objective of laying down common EU rules on the addition of vitamins, minerals and other substances to foods. The rules will apply in 6 months, although for a period of three years afterwards, products not in compliance can be marketed, if they were labeled or placed into the market prior to the regulations coming into force. The regulations call for an approved list of vitamins and minerals, with others not on the list allowable if on the market at the time the regulations coming into force and use supported by dossiers to be transferred to the European Food Safety Authority (EFSA) for evaluation. The Comiology procedure, based on scientific advice from EFSA will be used for determining minimum and maximum levels.
- European Parliament Passes Second Reading On Fortified Foods Regulations
The European Parliament voted yesterday on EU Fortified Foods Regulations yesterday, with the objective of laying down common EU rules on the addition of vitamins, minerals and other substances to foods. The rules will apply in 6 months, although for a period of three years afterwards, products not in compliance can be marketed, if they were labeled or placed into the market prior to the regulations coming into force. The regulations call for an approved list of vitamins and minerals, with others not on the list allowable if on the market at the time the regulations coming into force and use supported by dossiers to be transferred to the European Food Safety Authority (EFSA) for evaluation. The Comiology procedure, based on scientific advice from EFSA will be used for determining minimum and maximum levels.
- European Parliament Passes Second Reading On Fortified Foods Regulations
The European Parliament voted yesterday on EU Fortified Foods Regulations yesterday, with the objective of laying down common EU rules on the addition of vitamins, minerals and other substances to foods. The rules will apply in 6 months, although for a period of three years afterwards, products not in compliance can be marketed, if they were labeled or placed into the market prior to the regulations coming into force. The regulations call for an approved list of vitamins and minerals, with others not on the list allowable if on the market at the time the regulations coming into force and use supported by dossiers to be transferred to the European Food Safety Authority (EFSA) for evaluation. The Comiology procedure, based on scientific advice from EFSA will be used for determining minimum and maximum levels.
- Sageant Leads Grassroots Response to FTC Rule That Threatens Network Marketing
Sageant has launched a national grassroots campaign to secure responses to the recently proposed Federal Trade Commission (FTC) new rule on business opportunities.
- Sageant Leads Grassroots Response to FTC Rule That Threatens Network Marketing
Sageant has launched a national grassroots campaign to secure responses to the recently proposed Federal Trade Commission (FTC) new rule on business opportunities.
- NNFA Statement in Response to NIH State-of-the-Science Conference on Multivitamin/Mineral Supplements
In response to findings by the State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention, the National Nutritional Foods Association (NNFA) maintains that multivitamins and other mineral supplements taken by more than 100 million Americans daily are a safe, affordable and effective way to maintain a healthy lifestyle.
- NNFA Statement in Response to NIH State-of-the-Science Conference on Multivitamin/Mineral Supplements
In response to findings by the State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention, the National Nutritional Foods Association (NNFA) maintains that multivitamins and other mineral supplements taken by more than 100 million Americans daily are a safe, affordable and effective way to maintain a healthy lifestyle.
- NNFA Statement in Response to NIH State-of-the-Science Conference on Multivitamin/Mineral Supplements
In response to findings by the State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention, the National Nutritional Foods Association (NNFA) maintains that multivitamins and other mineral supplements taken by more than 100 million Americans daily are a safe, affordable and effective way to maintain a healthy lifestyle.
- NNFA Statement in Response to NIH State-of-the-Science Conference on Multivitamin/Mineral Supplements
In response to findings by the State-of-the-Science Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention, the National Nutritional Foods Association (NNFA) maintains that multivitamins and other mineral supplements taken by more than 100 million Americans daily are a safe, affordable and effective way to maintain a healthy lifestyle.
- FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease
The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect."
- FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease
The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect."
- FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease
The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect."
- FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease
The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect."
- FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease
The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect."
- FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease
The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect."
- FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease
The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect."
- FDA Finalizes Health Claim Associating Consumption of Barley Products with Reduction of Risk of Coronary Heart Disease
The Food and Drug Administration announced that it has finalized a rule that allows foods containing barley to claim that they reduce the risk of coronary heart disease. whole grain barley and dry milled barley products such as flakes, grits, flour, and pearled barley, which provide at least 0.75 grams of soluble fiber per serving, may bear the following claim: ""Soluble fiber from foods such as [name of food], as part of a diet low in saturated fat and cholesterol, may reduce the risk of heart disease. A serving of [name of food] supplies [x] grams of the soluble fiber necessary per day to have this effect."
- BioEnvelop Gains Registration with Health Canada for Manufacturing of Natural Health Products
Company has received a license to manufacture under the Natural Health
Products (NHP) certification program of Canada.
- BioEnvelop Gains Registration with Health Canada for Manufacturing of Natural Health Products
Company has received a license to manufacture under the Natural Health
Products (NHP) certification program of Canada.
- BioEnvelop Gains Registration with Health Canada for Manufacturing of Natural Health Products
Company has received a license to manufacture under the Natural Health
Products (NHP) certification program of Canada.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Embria Health Sciences' EpiCor Achieves Self-Determined GRAS Status
Company has successfully achieved self-determined Generally Regarded as Safe (GRAS) status with panelists including Theodore M. Farber, Ph.D., DABT (Chair) – Consulting Toxicologist, Norbert Page, Ph.D., DABT – Adjunct Professor of Toxicology at University of Maryland, Joseph Borzelleca, Ph.D., DABT – Professor Emeritus, Pharmacology and Toxicology at Medical College of Virginia and Virginia Commonwealth University and current editor for international journal, Food and Chemical Toxicology.
- Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods
Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods.
- Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods
Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods.
- Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods
Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods.
- Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods
Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods.
- Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods
Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods.
- Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods
Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods.
- Canada Approves Omega-3 EPA/DHA Ingredient For Most Foods
Company announces a significant Canadian regulatory approval enabling food manufacturers to include MEG-3® brand Omega-3 (EPA and DHA) ingredient in a broad range of foods.
- Enzymotec Receives NDI status for CardiaBeat(TM)
Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status.
- Enzymotec Receives NDI status for CardiaBeat(TM)
Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status.
- Enzymotec Receives NDI status for CardiaBeat(TM)
Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status.
- Enzymotec Receives NDI status for CardiaBeat(TM)
Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status.
- Enzymotec Receives NDI status for CardiaBeat(TM)
Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status.
- Enzymotec Receives NDI status for CardiaBeat(TM)
Company's CardiaBeat(TM) ingredient, which delivers conjugated plant sterol-DHA/EPA, receives NDI status.
- NIH Multivitamin/ Mineral Supplements Conference Report
This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention.
- NIH Multivitamin/ Mineral Supplements Conference Report
This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention.
- NIH Multivitamin/ Mineral Supplements Conference Report
This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention.
- NIH Multivitamin/ Mineral Supplements Conference Report
This conference summary was prepared by UNPA's Steve Ferraro, providing insights and commentary on the recent NIH Consensus Conference on Multivitamin/Mineral Supplements and Chronic Disease Prevention.
- Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act
UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA).
- Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act
UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA).
- Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act
UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA).
- Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act
UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA).
- Introduction of S. 3546 The Dietary Supplement and Non-Prescription Drug Consumer Protection Act
UNPA hailed the introduction in the United States Senate of bipartisan legislation to mandate the reporting of serious adverse events related to the consumption of dietary supplements, the 'Dietary Supplement and Non-Prescription Drug Consumer Protection Act', introduced by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL), Tom Harkin (D-IA), Mike Enzi (R-WY) and Edward Kennedy (D-MA).
- CRN Applauds Senators On AER Bill Introduction
CRN commends Senators Orrin Hatch (R-Utah), Tom Harkin (D-Iowa) and Richard Durbin (D-Ill.) for introducing S. 3546, “Dietary Supplement and Nonprescription Drug Consumer Act,” a bill that would require manufacturers to notify FDA of all serious adverse events (AEs) for dietary supplements and over-the-counter drugs (OTCs) reported to them.
- CRN Applauds Senators On AER Bill Introduction
CRN commends Senators Orrin Hatch (R-Utah), Tom Harkin (D-Iowa) and Richard Durbin (D-Ill.) for introducing S. 3546, “Dietary Supplement and Nonprescription Drug Consumer Act,” a bill that would require manufacturers to notify FDA of all serious adverse events (AEs) for dietary supplements and over-the-counter drugs (OTCs) reported to them.
- Introduction of AER Bill in U.S. Senate Announced
A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days.
- Introduction of AER Bill in U.S. Senate Announced
A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days.
- Introduction of AER Bill in U.S. Senate Announced
A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days.
- Introduction of AER Bill in U.S. Senate Announced
A press conference was held in the U.S. Capitol today to announce the introduction of legislation that will require companies that sell dietary supplements and over-the-counter drugs to submit serious adverse event reports that they receive from their customers to the Food and Drug Administration. The Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546), supported by Senators Orrin Hatch (R-UT), Richard Durbin (D-IL) and Tom Harkin (D-IA), will require companies to include on their products’ labels an address or phone number through which consumers can report adverse events that they associate with their use of a supplement or OTC drug. Companies will be obliged to inform FDA of any serious adverse event reports they receive within 15 business days.
- NNFA Statement on Adverse Event Reporting Legislation
NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements.
- NNFA Statement on Adverse Event Reporting Legislation
NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements.
- NNFA Statement on Adverse Event Reporting Legislation
NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements.
- NNFA Statement on Adverse Event Reporting Legislation
NNFA believes S.3564 – the Dietary Supplement and Non-Prescription Drug Consumer Protection Act, represents a fair and meaningful collaboration among the supplement industry, our bi-partisan champions in the Senate, and legislators who would like to see more stringent oversight of dietary supplements.
- GMP Compliance: An AHPA Tele-Seminar Series
AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published.
- GMP Compliance: An AHPA Tele-Seminar Series
AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published.
- GMP Compliance: An AHPA Tele-Seminar Series
AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published.
- GMP Compliance: An AHPA Tele-Seminar Series
AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published.
- GMP Compliance: An AHPA Tele-Seminar Series
AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published.
- GMP Compliance: An AHPA Tele-Seminar Series
AHPA has designed a series of tele-seminars on GMP compliance for supplement makers to cover GMP issues that are relevant both today and to assist in transitioning to the new rules when they are published.
- FDA Reaffirms: Nicotine Not Allowed in Dietary Supplements
FDA has informed a marketer of a product containing nicotine and labeled as a dietary supplement that the product “does not meet the definition of a dietary supplement [and] is an unapproved new drug whose marketing violates the [Federal Food, Drug, and Cosmetic Act].”
- FDA Reaffirms: Nicotine Not Allowed in Dietary Supplements
FDA has informed a marketer of a product containing nicotine and labeled as a dietary supplement that the product “does not meet the definition of a dietary supplement [and] is an unapproved new drug whose marketing violates the [Federal Food, Drug, and Cosmetic Act].”
- Citizens for Health Initiates Grassroots Advocacy Campaign in Support of Senators on AER Bill
Citizens for Health is mobilizing a major grassroots information campaign in support of the joint consumer-trade collaboration endorsing this bill by engaging its 108,000 consumer members.
- Citizens for Health Initiates Grassroots Advocacy Campaign in Support of Senators on AER Bill
Citizens for Health is mobilizing a major grassroots information campaign in support of the joint consumer-trade collaboration endorsing this bill by engaging its 108,000 consumer members.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
(Silver Spring, MD, June 9, 2006) -- The US Fish & Wildlife Service (FWS) has just announced that the export of wild American ginseng (Panax quinquefolius) roots that are at least 5 years old “will not be detrimental to the survival of the species,” and so will be allowed to be exported from states that maintain ginseng programs during the next three harvest seasons (2006–2008). This rule, contained in FWS’ issuance of its 2006 wild American ginseng findings, reestablishes the 5-year rule which had been in place since 1999 but which was set aside last year by a requirement that limited export to plants of at least 10 years of age. The establishment of the 10-year rule last August caught the ginseng trade off guard, and was followed by complaints that it had been developed without adequate input from all stakeholders. The ensuing outcry led the agency to hold four public meetings to “gather information from the public in preparation of our 2006 findings on the export of American ginseng roots.” Those meetings elicited a flood of comments from harvesters, growers, and exporters, and provided an opportunity for AHPA President Michael McGuffin to make a presentation that challenged some of the assumption that had gone into the 2005 findings. “Our concerns with the 10-year rule were centered on errors in some of the calculations used by FWS, and on the absence of any meaningful consideration of the positive impact that can come from harvesters who are also acting as ginseng stewards by replanting mature seeds,” said McGuffin. “The 2006 findings are founded on more accurate information, and we are pleased that FWS was willing to solicit comment and put it to good use.” To follow up on the public meetings earlier this year, AHPA has developed drafts of brochures on good stewardship harvest practices. FWS acknowledged in the 2006 findings note that it is “working with the American Herbal Products Association and other stakeholders” in the development of these brochures, “to reach out to diggers to encourage good stewardship practices for harvesting wild ginseng, and to inform them of current State and Federal requirements.” FWS’ annual wild American ginseng findings are prepared to address the issuance of permits under the Convention in International Trade in Endangered Species of Wild Fauna and Flora (CITES). Since 1975 American ginseng has been listed in CITES Appendix II — a species that is not necessarily now threatened with extinction but may become so unless trade is closely controlled. In order for Appendix II-listed species to enter into international trade, a determination must be made by the “scientific authority” in the country of origin that any harvest is both legally obtained and is not detrimental to the survival of the species. The Division of Scientific Authority at FWS serves in this role for the United States. The 2006 wild American ginseng findings can be found at http://www.fws.gov/international/pdf/2006ginsengfinding.pdf. A report on recommendations from the first public meeting held this past February are posted on the FWS website (http://www.fws.gov/international/animals/ginindx.html), and include links to presentations made by academics and industry.
###
The American Herbal Products Association (AHPA) represents the core of the botanical trade -- comprised of the finest growers, processors, manufacturers and marketers of herbal products -- AHPA’s mission is to promote the responsible commerce of herbal products. AHPA committees generate self-regulations to ensure the highest level of quality with respect to the way herbs are manufactured, labeled, and sold. Website: www.ahpa.org. |